Frequency of Sexual Intercourse,Women With Fibromyalgia

The Effect of Frequency of Sexual Intercourse on Symptoms in Women With Fibromyalgia

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05915403

Enrollment

200

Registered

2023-06-23

Start date

2021-12-01

Completion date

2023-02-01

Last updated

2023-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia, Pain, Depression

Brief summary

Does frequency of sexual intercourse affect symptom severity in female patients with fibromyalgia?

Interventions

DIAGNOSTIC_TESTFibromyalgia Impact Questionnaire

diagnostic tests

Study design

Observational model

CASE_CONTROL

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 55 Years

Healthy volunteers

Yes

Inclusion criteria

\* Female patient with fibromyalgia

Exclusion criteria

* Uncontrollable systemic disease (cardiovascular, pulmonary, hepatic, renal, hematological), * Major psychiatric disease, * Endocrine disease, * Pregnancy * Menopausal status, * Antihypertensive, antidepressant, anxiolytic, antiepileptic drugs use

Design outcomes

Primary

Measure	Time frame	Description
Visual Analog Scale	1 week	pain level 0-10, higher scores indicate worse outcome
frequency of sexual intercourse	3 mounths	mean monthly frequency of sexual intercourse in the last 3 months
Fibromyalgia Impact Questionnaire	1 week	0-80, higher scores indicate worse outcome

Secondary

Measure	Time frame	Description
Beck Depression Inventory	1 week	0-63, higher scores indicate worse outcome
Widespread Pain Index	1 week	0-19, higher scores indicate worse outcome
Symptom Severity Scale	1 week	0-12, higher scores indicate worse outcome

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026